GlassScriptPhysician profile
Heidi K Hansen
NPI 1184052458
$2,542.06
in general payments reported to CMS, 2019-2025
33 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $597 · 2021: $139 · 2022: $302 · 2023: $725 · 2024: $345 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978 · Travel and Lodging: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.23 |
| Travel and Lodging | $328.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $523.67 | 2020 | |
| Cook Medical LLC | $434.46 | 2019-2023 | Zenith |
| Silk Road Medical, INC. | $235.09 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Inari Medical, INC. | $198.44 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $115.09 | 2021-2025 | Angiojet Ultra 5000a, Innova Vascular |
| Shockwave Medical, INC | $92.87 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $82.88 | 2022 | |
| Becton, Dickinson and Company | $72.46 | 2024 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $71.95 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $69.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bridgebio Pharma, INC. | $58.35 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.56 | 2019-2020 | |
| Lemaitre Vascular, INC. | $38.56 | 2022-2023 | Artegraft Vascular Graft |
| Medtronic, INC. | $37.39 | 2022-2024 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $36.83 | 2020-2025 | Sapien 3 Ultra Resilia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $35.04 | 2021-2023 | Opsumit |
| Nevro Corp. | $34.82 | 2022 | |
| Endologix LLC | $34.48 | 2019-2022 | |
| Amgen INC. | $32.91 | 2019-2021 | |
| Organogenesis INC. | $32.17 | 2021-2023 | Puraply |
| Kci USA, INC. | $30.36 | 2021 | |
| Amarin Pharma, INC. | $29.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.79 | 2021-2024 | |
| Teleflex LLC | $19.67 | 2023 | Guideliner |
| Terumo Medical Corporation | $19.58 | 2019 | |
| W. L. Gore & Associates, INC. | $18.58 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Merck Sharp & Dohme LLC | $18.19 | 2024 | Bridion |
| E.R. Squibb & Sons, L.L.C. | $17.57 | 2025 | Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $16.65 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $16.49 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $15.98 | 2024 | Arcalyst |
| Cvrx, INC. | $14.19 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.